Erica Campagnaro

2.6k total citations
50 papers, 791 citations indexed

About

Erica Campagnaro is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Erica Campagnaro has authored 50 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 19 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Erica Campagnaro's work include Multiple Myeloma Research and Treatments (27 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Cancer Treatment and Pharmacology (7 papers). Erica Campagnaro is often cited by papers focused on Multiple Myeloma Research and Treatments (27 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Cancer Treatment and Pharmacology (7 papers). Erica Campagnaro collaborates with scholars based in United States, Canada and China. Erica Campagnaro's co-authors include Stuart H. Yuspa, Taghrid B. El-Abaseri, Susan Repertinger, Laura A. Hansen, Mark Kaminski, Moshe Talpaz, Asra Ahmed, Samuel A. Merrill, Ryan A. Wilcox and Sumana Devata and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Erica Campagnaro

48 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erica Campagnaro United States 13 331 319 215 146 136 50 791
Özge Uluçkan United States 17 88 0.3× 329 1.0× 284 1.3× 252 1.7× 58 0.4× 25 907
Boris Hügle Germany 19 416 1.3× 590 1.8× 58 0.3× 213 1.5× 48 0.4× 66 1.3k
P.A. Apoil France 20 187 0.6× 236 0.7× 69 0.3× 419 2.9× 65 0.5× 57 982
Brigitte Kasper Germany 15 412 1.2× 173 0.5× 272 1.3× 574 3.9× 148 1.1× 22 1.0k
Keith Shults United States 14 379 1.1× 301 0.9× 141 0.7× 294 2.0× 35 0.3× 23 991
Beatriz Sánchez-Correa Spain 20 283 0.9× 265 0.8× 509 2.4× 1.1k 7.8× 56 0.4× 26 1.6k
Julius A. Potian United States 7 84 0.3× 201 0.6× 129 0.6× 175 1.2× 107 0.8× 8 720
Sabrina Chiesa Italy 16 155 0.5× 407 1.3× 148 0.7× 607 4.2× 27 0.2× 35 1.1k
Zhihong Yang United States 11 119 0.4× 566 1.8× 125 0.6× 75 0.5× 29 0.2× 22 1.2k
Feras M. Ghazawi Canada 21 57 0.2× 272 0.9× 434 2.0× 246 1.7× 48 0.4× 71 1.3k

Countries citing papers authored by Erica Campagnaro

Since Specialization
Citations

This map shows the geographic impact of Erica Campagnaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica Campagnaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica Campagnaro more than expected).

Fields of papers citing papers by Erica Campagnaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erica Campagnaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica Campagnaro. The network helps show where Erica Campagnaro may publish in the future.

Co-authorship network of co-authors of Erica Campagnaro

This figure shows the co-authorship network connecting the top 25 collaborators of Erica Campagnaro. A scholar is included among the top collaborators of Erica Campagnaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erica Campagnaro. Erica Campagnaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, Terri L., Adam Rosenthal, Vaishali Sanchorawala, et al.. (2024). Isatuximab in Relapsed AL Amyloidosis: Results of a Prospective Phase II Trial (SWOG S1702). Blood. 144(Supplement 1). 3378–3378.
2.
Stino, Amro, Naresh Bumma, Rachel M. Smith, et al.. (2023). Lenalidomide in the treatment of anti‐myelin‐associated glycoprotein neuropathy: A phase 1 study to identify the maximum tolerated dose. European Journal of Neurology. 31(3). e16164–e16164. 5 indexed citations
3.
Dermody, Sarah M., Erica Campagnaro, Robbi A. Kupfer, Norman D. Hogikyan, & R. J. Morrison. (2021). Laryngotracheobronchial Amyloidosis: Patterns of Presentation and Management. Annals of Otology Rhinology & Laryngology. 131(7). 737–742. 1 indexed citations
4.
Keren, David F., Scott D. Gitlin, Erica Campagnaro, et al.. (2021). Multiple myeloma presenting as cryoglobulinemic vasculitis. JAAD Case Reports. 11. 81–83. 2 indexed citations
5.
Ahmed, Asra, Samuel A. Merrill, Paula Bockenstedt, et al.. (2019). Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. The Lancet Haematology. 6(12). e630–e637. 191 indexed citations
6.
Mazanec, Susan R., et al.. (2017). A family-centered intervention for the transition to living with multiple myeloma as a chronic illness: A pilot study. Applied Nursing Research. 35. 86–89. 14 indexed citations
7.
Wildes, Tanya M. & Erica Campagnaro. (2016). Management of multiple myeloma in older adults: Gaining ground with geriatric assessment. Journal of Geriatric Oncology. 8(1). 1–7. 19 indexed citations
8.
Raghupathy, Radha, Sabarish Ayyappan, Erica Campagnaro, et al.. (2016). Retrospective study of the incidence and patterns of arterial and venous thrombosis in Chinese versus African American patients with multiple myeloma. British Journal of Haematology. 176(2). 315–317. 5 indexed citations
9.
Caimi, Paolo F., Basem M. William, Pingfu Fu, et al.. (2015). Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients. Biology of Blood and Marrow Transplantation. 21(11). 1926–1931. 3 indexed citations
10.
Campagnaro, Erica, et al.. (2015). Management of Elderly Patients with Plasma Cell Myeloma. Drugs & Aging. 32(6). 427–442. 1 indexed citations
11.
Saiya-Cork, Kamlai, Brian Parkin, Peter Ouillette, et al.. (2011). A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 17(9). 2679–2692. 27 indexed citations
12.
Campagnaro, Erica, Aaron Balog, David R. Kaplan, et al.. (2011). Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance. Bone Marrow Transplantation. 47(9). 1212–1216. 17 indexed citations
13.
Jakubowiak, Andrzej, Tara Kendall, Ammar Al-Zoubi, et al.. (2009). Phase II Trial of Combination Therapy With Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Myeloma. Journal of Clinical Oncology. 27(30). 5015–5022. 57 indexed citations
14.
Jakubowiak, Andrzej, Craig C. Hofmeister, Erica Campagnaro, et al.. (2009). Lenalidomide, bortezomib, pegylated liposomal doxorubicin hydrochloride, and dexamethasone in newly diagnosed multiple myeloma: Initial results of phase I/II MMRC trial. Journal of Clinical Oncology. 27(15_suppl). 8517–8517. 4 indexed citations
15.
Campagnaro, Erica, Rima M. Saliba, Sergio Giralt, et al.. (2008). Symptom burden after autologous stem cell transplantation for multiple myeloma. Cancer. 112(7). 1617–1624. 33 indexed citations
16.
Repertinger, Susan, et al.. (2004). EGFR Enhances Early Healing After Cutaneous Incisional Wounding. Journal of Investigative Dermatology. 123(5). 982–989. 142 indexed citations
17.
Campagnaro, Erica, Kenneth J. Woodside, Shu‐Yuan Xiao, John A. Daller, & Bastiaan Evers. (2003). Cystosarcoma phyllodes (phyllodes tumor) of the male breast. Surgery. 133(6). 689–691. 9 indexed citations
18.
Copland, John A., Bruce A. Luxon, Tapati Maity, et al.. (2003). Genomic profiling identifies alterations in TGFβ signaling through loss of TGFβ receptor expression in human renal cell carcinogenesis and progression. Oncogene. 22(39). 8053–8062. 92 indexed citations
19.
Campagnaro, Erica, et al.. (2002). Disseminated Pseudallescheria boydii (Scedosporium apiospermum) infection in a renal transplant patient. Transplant Infectious Disease. 4(4). 207–211. 24 indexed citations
20.
Campagnaro, Erica, et al.. (1997). The effect of clenbuterol and recombinant erythropoietin on tumor growth and the anemia caused by the Walker 256 carcinosarcoma. Life Sciences. 61(25). 2475–2484. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Özge Uluçkan Breakdown of academic impact, for papers by Boris Hügle Breakdown of academic impact, for papers by P.A. Apoil Breakdown of academic impact, for papers by Brigitte Kasper Breakdown of academic impact, for papers by Keith Shults Breakdown of academic impact, for papers by Beatriz Sánchez-Correa Breakdown of academic impact, for papers by Julius A. Potian Breakdown of academic impact, for papers by Sabrina Chiesa Breakdown of academic impact, for papers by Zhihong Yang Breakdown of academic impact, for papers by Feras M. Ghazawi
Rankless by CCL
2026